“The low rates of completion and seroconversion argue for the need for a better vaccine with higher efficacy,” wrote Jain and her co-authors. To see if things have changed, the researchers did a subanalysis of newly diagnosed HIV patents. “No insurance or indigent care had higher rates of compliance to vaccination.” “In our study of PLWH, we found male sex and Black race were associated with low rates of completion of vaccination, while younger individuals were more likely to complete vaccination than older individuals,” according to the study. The study notes that the national Medical Monitoring Project reported that between 20, among the 44% of PLWH receiving medical care, 83% never received a single dose of the HBV vaccine during a year of follow-up care. Of the 6,925 cases reviewed, researchers found that only 658 PLWH (9%) received all three doses of the HBV vaccine within a year’s time. Comorbidities included hypertension (37.5%), hepatitis C (14.4%), and diabetes (14.1%). Most patients were male (70%), Black (53%), and Hispanic (26%). The study identified 6,925 PLWH who were eligible for the HBV vaccine. Related: Can the COVID-19 Vaccine Help Hepatitis B Patients? “However, unless current vaccination for PLWH can be improved or a curative treatment is developed, the (WHO 2030) target for HBV reduction will not be achieved.” “During the past decade considerable progress in HBV infection control have been achieved,” wrote Jain and colleagues. HBV vaccination, however, is an effective prevention strategy. Unlike HCV, which has antiviral medications that have a 95% cure rate, HBV has no cure. HBV is one of the leading causes of HCC and mortality among PLWH co-infected with HBV when there is incomplete suppression, the study notes. Texas has the highest rate of hepatocellular carcinoma (HCC) in the United States, according to the study. Gilead Sciences funded the study, which was published earlier this month as a short communication.
Jain, M.D., a professor at UT Southwestern Medical Center in Dallas, and the study’s corresponding author. “The more we can use self-collected tests, we minimise resources required, expand testing capabilities, and ultimately track and treat as needed.”Įarlier this month, NOWDiagnostics collaborated with the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) for the development of a rapid Covid-19 antibody test.“Understanding the effectiveness of current HBV vaccination implementation can inform strategies to improve outcomes of new HBV vaccine roll-out currently underway in PLWH to eliminate HBV,” wrote corresponding author Mamta J. It is also said to manage the country’s largest Covid-19 testing site at Dodgers Stadium in Los Angeles.Ĭurative CEO Fred Turner said: Asymptomatic people living in the San Antonio area have an opportunity to make a real difference in the future of Covid-19 testing by participating in this study. Curative is said to manage the country’s largest Covid-19 testing site in Los AngelesĬurative stated that it has tested more than four million samples across the US and tests about 70,000 samples per day.
The startup also launched a new CLIA-certified laboratory facility in Pflugerville of Texas to boost both availability and processing capacity for the state by 10,000 tests per day by using its FDA authorised oral fluid Covid-19 test. The study will evaluate the patients with Covid-related symptoms, which meet the Centers for Disease Control and Prevention (CDC) guidelines as assessed by a healthcare practitioner.Ĭurative is engaged in expanding access to testing through next-generation testing with mobile vans and kiosks across Texas, including remote areas. The new research study, which has been started in the City of San Antonio, intends to better understand how video-assisted self-collected oral swab samples and nasal swab samples compare to provider-collected nasal swab samples to identify Covid-19.Īccording to Curative, the self-collected samples enable to decrease dependence on the supply of personal protective equipment such as masks, gloves and lab coats, as well as avoid potential exposure of our doctors or nurses to novel coronavirus. (Credit: Pete Linforth from Pixabay)Ĭurative, a startup established for Covid-19 testing, has begun a research study to evaluate the efficacy of self-collected Covid-19 tests. The new research study is conducted in the City of San Antonio.
The study will assess the patients with Covid-related symptoms, which meet the CDC guidelines as assessed by a healthcare practitioner
0 kommentar(er)
